Compare VTSI & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTSI | BNTC |
|---|---|---|
| Founded | 1993 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.9M | 405.7M |
| IPO Year | N/A | N/A |
| Metric | VTSI | BNTC |
|---|---|---|
| Price | $4.56 | $12.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $7.00 | ★ $28.25 |
| AVG Volume (30 Days) | 53.9K | ★ 235.3K |
| Earning Date | 11-10-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $24,934,267.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.39 | N/A |
| P/E Ratio | $331.53 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.57 | $9.70 |
| 52 Week High | $7.49 | $17.15 |
| Indicator | VTSI | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 30.99 | 40.35 |
| Support Level | $4.79 | $12.78 |
| Resistance Level | $4.94 | $13.68 |
| Average True Range (ATR) | 0.14 | 0.75 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 0.82 | 28.74 |
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.